Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on March 21, 2007
Accepted on April 26, 2007
A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
Anna Helgadottir 1, Gudmar Thorleifsson 1, Andrei Manolescu 1, Solveig Gretarsdottir 1, Thorarinn Blondal 1, Aslaug Jonasdottir 1, Adalbjorg Jonasdottir 1, Asgeir Sigurdsson 1, Adam Baker 1, Arnar Palsson , Gisli Masson 1, Daniel Gudbjartsson 1, Kristinn P. Magnusson 1, Karl Andersen 2, Allan I. Levey 3, Valgerdur M. Backman 1, Sigurborg Matthiasdottir 1, Thorbjorg Jonsdottir 1, Stefan Palsson 1, Helga Einarsdottir 1, Steinunn Gunnarsdottir 1, Arnaldur Gylfason 1, Viola Vaccarino 3, W. Craig Hooper 3, Muredach P. Reilly 4, Christopher B. Granger 5, Harland Austin 3, Daniel J. Rader 4, Svati H. Shah 5, Arshed A. Quyyumi 3, Jeffrey R. Gulcher 1, Gudmundur Thorgeirsson 3, Unnur Thorsteinsdottir 1, Augustine Kong 1*, Kari Stefansson 1*
1 deCODE genetics Inc, Reykjavik, Iceland. 2 National University Hospital, Reykjavik, Iceland. 3 Emory University School of Medicine, Atlanta, GA 30322, USA. 4 University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. 5 Duke University School of Medicine, Durham, NC 27710, USA.
* To whom correspondence should be addressed.
Augustine Kong , E-mail: augustine.kong{at}decode.is Kari Stefansson , E-mail: kstefans{at}decode.is
The global endemic of cardiovascular diseases calls for improvedrisk assessment and treatment. Here we describe an associationbetween myocardial infarction (MI) and a common sequence varianton chromosome 9p21. This study included a total of 4587 casesand 12,769 controls. The identified variant, adjacent to thetumor suppressor genes CDKN2A and CDKN2B, was associated tothe disease with high significance (P = 1.2 x 10-20). Approximately21% of individuals in the population are homozygous for thisvariant and they have an estimated 1.64-fold greater risk ofsuffering myocardial infarction than non-carriers. The correspondingrisk is 2.02-fold for early onset cases. The population attributablerisk (PAR) is 21% for MI in general and 31% for early onsetcases.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
LETTERS
Erik Rifkin, Edward Bouwer;, Kari Stefansson, and Augustine Kong (7 September 2007) Science317 (5843), 1322b.
[DOI: 10.1126/science.317.5843.1322b] |Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genetics and the general physician: insights, applications and future challenges.
No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents.
P. Hoppmann, A. Erl, S. Turk, K. Tiroch, J. Mehilli, A. Schomig, A. Kastrati, and W. Koch (2009)
J. Am. Coll. Cardiol. Intv.
2, 1149-1155
|Abstract »|Full Text »|PDF »
Irrelevance of the Chromosome 9p21.3 Locus for Acute Cardiovascular Events and Restenosis.
B. D. Horne and J. L. Anderson (2009)
J. Am. Coll. Cardiol. Intv.
2, 1156-1157
|Full Text »|PDF »
A Common Copy Number Variation on Chromosome 6 Association With the Gene Expression Level of Endothelin 1 in Transformed B Lymphocytes From Three Racial Groups.
Y. V. Sun, P. A. Peyser, and S. L.R. Kardia (2009)
Circ Cardiovasc Genet
2, 483-488
|Abstract »|Full Text »|PDF »
Multi-Ethnic Genetic Association Study of Carotid Intima-Media Thickness Using a Targeted Cardiovascular SNP Microarray.
M. B. Lanktree, R. A. Hegele, S. Yusuf, and S. S. Anand (2009)
Stroke
40, 3173-3179
|Abstract »|Full Text »|PDF »
A quantitative model for age-dependent expression of the p16INK4a tumor suppressor.
D. Tsygankov, Y. Liu, H. K. Sanoff, N. E. Sharpless, and T. C. Elston (2009)
PNAS
106, 16562-16567
|Abstract »|Full Text »|PDF »
9p21 is a Shared Susceptibility Locus Strongly for Coronary Artery Disease and Weakly for Ischemic Stroke in Chinese Han Population.
H. Ding, Y. Xu, X. Wang, Q. Wang, L. Zhang, Y. Tu, J. Yan, W. Wang, R. Hui, C.-Y. Wang, et al. (2009)
Circ Cardiovasc Genet
2, 338-346
|Abstract »|Full Text »|PDF »
The 9p21 Myocardial Infarction Risk Allele Increases Risk of Peripheral Artery Disease in Older People.
C. Cluett, M. M. McDermott, J. Guralnik, L. Ferrucci, S. Bandinelli, I. Miljkovic, J. M. Zmuda, R. Li, G. Tranah, T. Harris, et al. (2009)
Circ Cardiovasc Genet
2, 347-353
|Abstract »|Full Text »|PDF »
Evidence for Association between Polycystic Ovary Syndrome (PCOS) and TCF7L2 and Glucose Intolerance in Women with PCOS and TCF7L2.
A. Biyasheva, R. S. Legro, A. Dunaif, and M. Urbanek (2009)
J. Clin. Endocrinol. Metab.
94, 2617-2625
|Abstract »|Full Text »|PDF »
A genetic variant on chromosome 9p21 and incident heart failure in the ARIC study.
K. Yamagishi, A. R. Folsom, W. D. Rosamond, E. Boerwinkle, and for the ARIC Investigators (2009)
Eur. Heart J.
30, 1222-1228
|Abstract »|Full Text »|PDF »
Genetic architecture of quantitative traits in mice, flies, and humans.
Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-{alpha} via the p38 mitogen-activated protein kinase pathway.
Y. Zhang, B.-S. Herbert, G. Rajashekhar, D. A. Ingram, M. C. Yoder, M. Clauss, and J. Rehman (2009)
FASEB J
23, 1358-1365
|Abstract »|Full Text »|PDF »
Large Scale Association Analysis of Novel Genetic Loci for Coronary Artery Disease.
The Year in Epidemiology, Health Services Research, and Outcomes Research.
M. A. Hlatky and P. A. Heidenreich (2009)
J. Am. Coll. Cardiol.
53, 1459-1466
|Full Text »|PDF »
Analysis of Complex Disease Association and Linkage Studies Using the University of California Santa Cruz Genome Browser.
T. Wang and T. S. Furey (2009)
Circ Cardiovasc Genet
2, 199-204
|Full Text »|PDF »
High Myopia Is Not Associated with the SNPs in the TGIF, Lumican, TGFB1, and HGF Genes.
P. Wang, S. Li, X. Xiao, X. Jia, X. Jiao, X. Guo, and Q. Zhang (2009)
Invest. Ophthalmol. Vis. Sci.
50, 1546-1551
|Abstract »|Full Text »|PDF »
Association and Functional Analyses of MEF2A as a Susceptibility Gene for Premature Myocardial Infarction and Coronary Artery Disease.
I. Guella, V. Rimoldi, R. Asselta, D. Ardissino, M. Francolini, N. Martinelli, D. Girelli, F. Peyvandi, M. Tubaro, P. A. Merlini, et al. (2009)
Circ Cardiovasc Genet
2, 165-172
|Abstract »|Full Text »|PDF »
Common Genetic Variants on Chromosome 9p21 Confers Risk of Ischemic Stroke: A Large-Scale Genetic Association Study.
J. G. Smith, O. Melander, H. Lovkvist, B. Hedblad, G. Engstrom, P. Nilsson, J. Carlson, G. Berglund, B. Norrving, and A. Lindgren (2009)
Circ Cardiovasc Genet
2, 159-164
|Abstract »|Full Text »|PDF »
STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement.
J. Little, J. P.T. Higgins, J. P.A. Ioannidis, D. Moher, F. Gagnon, E. von Elm, M. J. Khoury, B. Cohen, G. Davey-Smith, J. Grimshaw, et al. (2009)
Ann Intern Med
150, 206-215
|Abstract »|Full Text »|PDF »
Genome-wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors..
K. Ding and I. J. Kullo (2009)
Circ Cardiovasc Genet
2, 63-72
|Full Text »|PDF »
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts.
B. M. Psaty, C. J. O'Donnell, V. Gudnason, K. L. Lunetta, A. R. Folsom, J. I. Rotter, A. G. Uitterlinden, T. B. Harris, J. C.M. Witteman, E. Boerwinkle, et al. (2009)
Circ Cardiovasc Genet
2, 73-80
|Abstract »|Full Text »|PDF »
Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers.
Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology.
P. R Burton, A. L Hansell, I. Fortier, T. A Manolio, M. J Khoury, J. Little, and P. Elliott (2009)
Int. J. Epidemiol.
38, 263-273
|Abstract »|Full Text »|PDF »
Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3.
N. P. Paynter, D. I. Chasman, J. E. Buring, D. Shiffman, N. R. Cook, and P. M. Ridker (2009)
Ann Intern Med
150, 65-72
|Abstract »|Full Text »|PDF »
Stem Cells Use Distinct Self-renewal Programs at Different Ages.
B.P. Levi and S.J. Morrison (2009)
Cold Spring Harb Symp Quant Biol
|Abstract »|PDF »
Prevalence in the United States of Selected Candidate Gene Variants: Third National Health and Nutrition Examination Survey, 1991-1994.
M.-h. Chang, M. L. Lindegren, M. A. Butler, S. J. Chanock, N. F. Dowling, M. Gallagher, R. Moonesinghe, C. A. Moore, R. M. Ned, M. R. Reichler, et al. (2009)
Am. J. Epidemiol.
169, 54-66
|Abstract »|Full Text »|PDF »
CHAPTER 9 Genetics of Cardiovascular Diseases.
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth (2009)
ESC Textbook of Cardiovascular Medicine
2, med-9780199566990-chapter
|Abstract »|Full Text »|PDF »
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.
A. D. Johnson, R. E. Handsaker, S. L. Pulit, M. M. Nizzari, C. J. O'Donnell, and P. I. W. de Bakker (2008)
Bioinformatics
24, 2938-2939
|Abstract »|Full Text »|PDF »
Chromosome 9p21 and Cardiovascular Disease: The Story Unfolds.
N. J. Samani and H. Schunkert (2008)
Circ Cardiovasc Genet
1, 81-84
|Full Text »|PDF »
Association of Variation in the Chromosome 9p21 Locus With Myocardial Infarction Versus Chronic Coronary Artery Disease.
B. D. Horne, J. F. Carlquist, J. B. Muhlestein, T. L. Bair, and J. L. Anderson (2008)
Circ Cardiovasc Genet
1, 85-92
|Abstract »|Full Text »|PDF »
The complex genetics of multiple sclerosis: pitfalls and prospects.
Athsq1 Is an Atherosclerosis Modifier Locus With Dramatic Effects on Lesion Area and Prominent Accumulation of Versican.
S. B. Seidelmann, C. Kuo, N. Pleskac, J. Molina, S. Sayers, R. Li, J. Zhou, P. Johnson, K. Braun, C. Chan, et al. (2008)
Arterioscler Thromb Vasc Biol
28, 2180-2186
|Abstract »|Full Text »|PDF »
Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis.
G. S. Sagoo, I. Tatt, G. Salanti, A. S. Butterworth, N. Sarwar, M. van Maarle, J. W. Jukema, B. Wiman, J. J. P. Kastelein, A. M. Bennet, et al. (2008)
Am. J. Epidemiol.
168, 1233-1246
|Abstract »|Full Text »|PDF »
Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes.
A. Doria, J. Wojcik, R. Xu, E. V. Gervino, T. H. Hauser, M. T. Johnstone, D. Nolan, F. B. Hu, and J. H. Warram (2008)
JAMA
300, 2389-2397
|Abstract »|Full Text »|PDF »
Hypercoagulable States in Cardiovascular Disease.
M. Y. Chan, F. Andreotti, and R. C. Becker (2008)
Circulation
118, 2286-2297
|Full Text »|PDF »
Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes.
M. I. McCarthy and A. T. Hattersley (2008)
Diabetes
57, 2889-2898
|Full Text »|PDF »
Associations Between Single Nucleotide Polymorphisms on Chromosome 9p21 and Risk of Coronary Heart Disease in Chinese Han Population.
L. Zhou, X. Zhang, M. He, L. Cheng, Y. Chen, F. B. Hu, and T. Wu (2008)
Arterioscler Thromb Vasc Biol
28, 2085-2089
|Abstract »|Full Text »|PDF »
Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk.
H. Lango, the U.K. Type 2 Diabetes Genetics Consortium, C. N.A. Palmer, A. D. Morris, E. Zeggini, A. T. Hattersley, M. I. McCarthy, T. M. Frayling, and M. N. Weedon (2008)
Diabetes
57, 3129-3135
|Abstract »|Full Text »|PDF »
Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants.
K. L. Mohlke, M. Boehnke, and G. R. Abecasis (2008)
Hum. Mol. Genet.
17, R102-R108
|Abstract »|Full Text »|PDF »
Association Between the Coronary Artery Disease Risk Locus on Chromosome 9p21.3 and Abdominal Aortic Aneurysm.
M. J. Bown, P. S. Braund, J. Thompson, N. J.M. London, N. J. Samani, and R. D. Sayers (2008)
Circ Cardiovasc Genet
1, 39-42
|Abstract »|Full Text »|PDF »
Cardiovascular Genomics, Personalized Medicine, and the National Heart, Lung, and Blood Institute: Part I: The Beginning of an Era.
C. J. O'Donnell and E. G. Nabel (2008)
Circ Cardiovasc Genet
1, 51-57
|Full Text »|PDF »
HapMap and Mapping Genes for Cardiovascular Disease.
K. Musunuru and S. Kathiresan (2008)
Circ Cardiovasc Genet
1, 66-71
|Full Text »|PDF »
Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia.
J. B. van der Net, D. M. Oosterveer, J. Versmissen, J. C. Defesche, M. Yazdanpanah, B. E. Aouizerat, E. W. Steyerberg, M. J. Malloy, C. R. Pullinger, J. J.P. Kastelein, et al. (2008)
Eur. Heart J.
29, 2195-2201
|Abstract »|Full Text »|PDF »
Genome-wide association studies of coronary artery disease: have the results of replication studies been replicable?.
C.-K. Heng (2008)
Eur. Heart J.
29, 2189-2190
|Full Text »|PDF »
Coronary Artery Disease-Associated Locus on Chromosome 9p21 and Early Markers of Atherosclerosis.
N. J. Samani, O. T. Raitakari, K. Sipila, M. D. Tobin, H. Schunkert, M. Juonala, P. S. Braund, J. Erdmann, J. Viikari, L. Moilanen, et al. (2008)
Arterioscler Thromb Vasc Biol
28, 1679-1683
|Abstract »|Full Text »|PDF »
A Weighted-Holm Procedure Accounting for Allele Frequencies in Genomewide Association Studies.
An MCMC algorithm for haplotype assembly from whole-genome sequence data.
V. Bansal, A. L. Halpern, N. Axelrod, and V. Bafna (2008)
Genome Res.
18, 1336-1346
|Abstract »|Full Text »|PDF »
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study.
T. L. Assimes, J. W. Knowles, A. Basu, C. Iribarren, A. Southwick, H. Tang, D. Absher, J. Li, J. M. Fair, G. D. Rubin, et al. (2008)
Hum. Mol. Genet.
17, 2320-2328
|Abstract »|Full Text »|PDF »
Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians.
M. C.Y. Ng, K. S. Park, B. Oh, C. H.T. Tam, Y. M. Cho, H. D. Shin, V. K.L. Lam, R. C.W. Ma, W. Y. So, Y. S. Cho, et al. (2008)
Diabetes
57, 2226-2233
|Abstract »|Full Text »|PDF »
Association of Genetic Variation on Chromosome 9p21 With Susceptibility and Progression of Atherosclerosis: A Population-Based, Prospective Study.
S. Ye, J. Willeit, F. Kronenberg, Q. Xu, and S. Kiechl (2008)
J. Am. Coll. Cardiol.
52, 378-384
|Abstract »|Full Text »|PDF »
Gaining Insights in Coronary Disease Genomics.
S. S. Murray and E. J. Topol (2008)
J. Am. Coll. Cardiol.
52, 385-386
|Full Text »|PDF »
Genomics in cardiac metabolism.
J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw (2008)
Cardiovasc Res
79, 218-227
|Abstract »|Full Text »|PDF »
Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery.
G. D. Lewis, A. Asnani, and R. E. Gerszten (2008)
J. Am. Coll. Cardiol.
52, 117-123
|Abstract »|Full Text »|PDF »
Approaches for Unraveling the Joint Genetic Determinants of Schizophrenia and Bipolar Disorder.
Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.
B. S. Sutton, D. R. Crosslin, S. H. Shah, S. C. Nelson, A. Bassil, A. B. Hale, C. Haynes, P. J. Goldschmidt-Clermont, J. M. Vance, D. Seo, et al. (2008)
Hum. Mol. Genet.
17, 1318-1328
|Abstract »|Full Text »|PDF »
Whole Genome Analyses Suggest Ischemic Stroke and Heart Disease Share an Association With Polymorphisms on Chromosome 9p21.
M. Matarin, W. M. Brown, A. Singleton, J. A. Hardy, J. F. Meschia, and for the ISGS investigators (2008)
Stroke
39, 1586-1589
|Abstract »|Full Text »|PDF »
Angiotensin II Type 1 Receptor 1166C Polymorphism Is Associated With Abdominal Aortic Aneurysm in Three Independent Cohorts.
G. T. Jones, A. R. Thompson, F. M. van Bockxmeer, H. Hafez, J. A. Cooper, J. Golledge, S. E. Humphries, P. E. Norman, and A. M. van Rij (2008)
Arterioscler Thromb Vasc Biol
28, 764-770
|Abstract »|Full Text »|PDF »
Where Do We Go for Atherothrombotic Disease Genetics?.
S.-M. Brand-Herrmann (2008)
Stroke
39, 1070-1075
|Full Text »|PDF »
Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease.
H. Schunkert, A. Gotz, P. Braund, R. McGinnis, D.-A. Tregouet, M. Mangino, P. Linsel-Nitschke, F. Cambien, C. Hengstenberg, K. Stark, et al. (2008)
Circulation
117, 1675-1684
|Abstract »|Full Text »|PDF »
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events.
S. Kathiresan, O. Melander, D. Anevski, C. Guiducci, N. P. Burtt, C. Roos, J. N. Hirschhorn, G. Berglund, B. Hedblad, L. Groop, et al. (2008)
N. Engl. J. Med.
358, 1240-1249
|Abstract »|Full Text »|PDF »
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.
H. M. Broadbent, J. F. Peden, S. Lorkowski, A. Goel, H. Ongen, F. Green, R. Clarke, R. Collins, M. G. Franzosi, G. Tognoni, et al. (2008)
Hum. Mol. Genet.
17, 806-814
|Abstract »|Full Text »|PDF »
Can Fishing for New Genes Catch Patients at Risk of Coronary Artery Disease?.
J. Emmerich and P. M Ridker (2008)
Clin. Chem.
54, 453-455
|Full Text »|PDF »
Chromosome 9p21.3 Coronary Heart Disease Locus Genotype and Prospective Risk of CHD in Healthy Middle-Aged Men.
P. J. Talmud, J. A. Cooper, J. Palmen, R. Lovering, F. Drenos, A. D. Hingorani, and S. E. Humphries (2008)
Clin. Chem.
54, 467-474
|Abstract »|Full Text »|PDF »
New cardiovascular risk determinants do exist and are clinically useful.
Y. M. Smulders, A. Thijs, and J. W. Twisk (2008)
Eur. Heart J.
29, 436-440
|Abstract »|Full Text »|PDF »
Four SNPs on Chromosome 9p21 in a South Korean Population Implicate a Genetic Locus That Confers High Cross-Race Risk for Development of Coronary Artery Disease.
G.-Q. Shen, L. Li, S. Rao, K. G. Abdullah, J. M. Ban, B.-S. Lee, J. E. Park, and Q. K. Wang (2008)
Arterioscler Thromb Vasc Biol
28, 360-365
|Abstract »|Full Text »|PDF »
Commentary: Genetic association studies see light at the end of the tunnel.
T. M Frayling (2008)
Int. J. Epidemiol.
37, 133-135
|Full Text »|PDF »
Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women.
P. M Ridker, D. I. Chasman, R. Y.L. Zee, A. Parker, L. Rose, N. R. Cook, J. E Buring, and for the Women's Genome Health Study Working Group (2008)
Clin. Chem.
54, 249-255
|Abstract »|Full Text »|PDF »
Update on the Genetics of Stroke and Cerebrovascular Disease 2007.
R. A. Hegele and M. Dichgans (2008)
Stroke
39, 252-254
|Full Text »|PDF »
Surprises of the genome and "personalized" medicine..
A. J. Marian (2008)
J. Am. Coll. Cardiol.
51, 456-458
|Full Text »|PDF »
Required sample size and nonreplicability thresholds for heterogeneous genetic associations.
R. Moonesinghe, M. J. Khoury, T. Liu, and J. P. A. Ioannidis (2008)
PNAS
105, 617-622
|Abstract »|Full Text »|PDF »
Genome-Wide Association: Which Do You Want First: the Good News, the Bad News, or the Good News?.
K. D. Taylor, J. M. Norris, and J. I. Rotter (2007)
Diabetes
56, 2844-2848
|Full Text »|PDF »
Future Use of Genomics in Coronary Artery Disease.